Clay B. Siegall, Ph.D. is perhaps well-known to those who know of Seattle Genetics or even cancer therapy but for those who remain unfamiliar with Siegall, fret not. Here is some additional info on the subject in question:
It all began with an education. He has earned a bachelor’s of science degree in Zoology from the University of Maryland in College Park, Maryland as well as a doctorate in Genetics from George Washington University in Washington, D.C. From 1988 to 1991 he worked for the National Cancer Institute, National Institutes of Health and then from 1991 to 1997 he was employed by the Bristol-Myers company.
Siegall is currently the co-founder of Seattle Genetics. He is also the company president, chief executive officer (CEO) and chairman of the board as well. He is actually a trained scientist who has focused his studies on cancer therapies.
His company, Seattle Genetics, was founded on the principles of assisting patients, drug development practices, research and innovative science. His company is also reportedly at the top in terms of the development of antibody-drug conjugates (ADCs). In fact, they scored an FDA approval of their very first ADC named Adcetris (or (brentuximab vedotin) back in 2011.
Through a business partnership with the Takeda Pharmaceutical Company, Adcetris is said to be marketed around the world and has been OKed for use in 60 plus countries. The company is also moving ahead with what they specifically refer to as a unique “pipeline of proprietary ADCs” to treat cancer.
Siegall and his company have entered into licensing deals for their ADC tech as well. This includes agreements with numerous other well-known companies such as Pfizer, Abbvie, and Genentech. There are almost two dozen different ADCs being developed using their technology.
He has raised a significant amount of finances for his company and written a number of works related to his areas of expertise. He has also received a number of different awards. Said awards include the 2013 University of Maryland Alumnus of the Year for Computer, Math and Natural Sciences among other honors.
Learn more here: